Literature DB >> 19707849

Effects of epigallocatechin gallate on rotenone-injured murine brain cultures.

Rudolf Moldzio1, Khaled Radad, Christopher Krewenka, Barbara Kranner, Johanna Catharina Duvigneau, Yingzi Wang, Wolf-Dieter Rausch.   

Abstract

Green tea polyphenol epigallocatechin-3-gallate (EGCG) is reported to have antioxidant abilities and to counteract beneficially mitochondrial impairment and oxidative stress. The present study was designed to investigate neuroprotective effects of EGCG on rotenone-treated dissociated mesencephalic cultures and organotypic striatal cultures. Rotenone is a potent inhibitor of complex I of the respiratory chain, which in vitro causes pathological and neurochemical characteristics of diseases in which mitochondrial impairment is involved, e.g., Parkinson's disease. Treatment with EGCG (0.1, 1, 10 muM) alone had no significant effects on mesencephalic cultures. In striatal slice cultures, EGCG led to a significant increase of propidium iodide (PI) uptake and 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM), but not dihydroethidium (DHE) fluorescence intensity. Rotenone (20 nM on the eighth DIV for 48 h) significantly decreased the numbers and the neurite lengths of TH ir neurons by 23 and 34% in dissociated mesencephalic cell cultures compared to untreated controls. Exposure of striatal slices to rotenone (0.5 mM for 48 h) significantly increased PI uptake, and DAF-FM and DHE fluorescence intensities by 41 and 136 and 19%, respectively, compared to controls. Against rotenone, in dissociated mesencephalic cultures, EGCG produced no significant effect on either the number or neurite lengths of THir neurons compared to rotenone-treated cultures, but EGCG significantly decreased PI uptake by 19% and DAF-FM fluorescence intensity by 19 and 58%, respectively, compared to increase in rotenone-exposed striatal slices. On the other hand, EGCG did not affect superoxide (O(2) (-)) formation as detected with DHE. These data indicate that EGCG slightly protects striatal slices by counteracting nitric oxide (NO(.)) production by rotenone. In conclusion, EGCG partially protects striatal slices but not dissociated cells against rotenone toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19707849     DOI: 10.1007/s00702-009-0284-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  36 in total

Review 1.  Use of phytotherapy in dentistry.

Authors:  Francisco Carlos Groppo; Cristiane de Cássia Bergamaschi; Karina Cogo; Michelle Franz-Montan; Rogério Heládio Lopes Motta; Eduardo Dias de Andrade
Journal:  Phytother Res       Date:  2008-08       Impact factor: 5.878

2.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

3.  Protective effects of tea polyphenols against oxidative damage to red blood cells.

Authors:  L N Grinberg; H Newmark; N Kitrossky; E Rahamim; M Chevion; E A Rachmilewitz
Journal:  Biochem Pharmacol       Date:  1997-11-01       Impact factor: 5.858

4.  On-line high-performance liquid chromatography analysis of the antioxidant activity of phenolic compounds in green and black tea.

Authors:  Amanda J Stewart; William Mullen; Alan Crozier
Journal:  Mol Nutr Food Res       Date:  2005-01       Impact factor: 5.914

Review 5.  Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.

Authors:  Nurulain T Zaveri
Journal:  Life Sci       Date:  2006-01-30       Impact factor: 5.037

6.  Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration.

Authors:  Khaled Radad; Wolf-Dieter Rausch; Gabriele Gille
Journal:  Neurochem Int       Date:  2006-03-31       Impact factor: 3.921

7.  (-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant.

Authors:  Kaoru Nagai; Min Hai Jiang; Junichi Hada; Tetsu Nagata; Yukio Yajima; Satoshi Yamamoto; Tomoyuki Nishizaki
Journal:  Brain Res       Date:  2002-11-29       Impact factor: 3.252

8.  Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue.

Authors:  M Suganuma; S Okabe; M Oniyama; Y Tada; H Ito; H Fujiki
Journal:  Carcinogenesis       Date:  1998-10       Impact factor: 4.944

9.  Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells.

Authors:  Woon-Gye Chung; Cristobal L Miranda; Claudia S Maier
Journal:  Brain Res       Date:  2007-08-22       Impact factor: 3.252

10.  Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons.

Authors:  Emily K Schroeder; Natalie A Kelsey; Jeanne Doyle; Elise Breed; Ron J Bouchard; F Alexandra Loucks; R Alex Harbison; Daniel A Linseman
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

View more
  10 in total

1.  Neuroprotective effects of white tea against oxidative stress-induced toxicity in striatal cells.

Authors:  M P Almajano; I Vila; S Gines
Journal:  Neurotox Res       Date:  2011-06-23       Impact factor: 3.911

2.  Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro.

Authors:  Dae-Hee Lee; Cuk-Seong Kim; Yong J Lee
Journal:  Food Chem Toxicol       Date:  2010-11-05       Impact factor: 6.023

Review 3.  Therapeutic properties of green tea against environmental insults.

Authors:  Lixia Chen; Huanbiao Mo; Ling Zhao; Weimin Gao; Shu Wang; Meghan M Cromie; Chuanwen Lu; Jia-Sheng Wang; Chwan-Li Shen
Journal:  J Nutr Biochem       Date:  2016-05-27       Impact factor: 6.048

4.  Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway.

Authors:  Samir Nath; Muznabanu Bachani; Deepti Harshavardhana; Joseph P Steiner
Journal:  J Neurovirol       Date:  2012-08-11       Impact factor: 2.643

5.  Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease.

Authors:  Natália Bitu Pinto; Bruno da Silva Alexandre; Kelly Rose Tavares Neves; Aline Holanda Silva; Luzia Kalyne A M Leal; Glauce S B Viana
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-18       Impact factor: 2.629

6.  Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7.

Authors:  Xijin Wang; Qiang Guan; Meihua Wang; Liu Yang; Jie Bai; Zhiqiang Yan; Yuhong Zhang; Zhenguo Liu
Journal:  Drug Des Devel Ther       Date:  2015-05-07       Impact factor: 4.162

7.  The protective role of (-)-epigallocatechin-3-gallate in thrombin-induced neuronal cell apoptosis and JNK-MAPK activation.

Authors:  Qianqian He; Lei Bao; Jeffrey Zimering; Kun Zan; Zuohui Zhang; Hongjuan Shi; Jie Zu; Xinxin Yang; Fang Hua; Xinchun Ye; Guiyun Cui
Journal:  Neuroreport       Date:  2015-05-06       Impact factor: 1.837

Review 8.  Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson's Disease.

Authors:  Mark F McCarty; Aaron Lerner
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 9.  From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview.

Authors:  Wolf-Dieter Rausch; Feixue Wang; Khaled Radad
Journal:  J Neural Transm (Vienna)       Date:  2022-04-23       Impact factor: 3.850

Review 10.  Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.

Authors:  Priscila Baltazar Gonçalves; Ana Carolina Rennó Sodero; Yraima Cordeiro
Journal:  Biomolecules       Date:  2021-05-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.